Summary
We previously identified a CD2-initiated signaling pathway which inhibits activation-induced cell death in mitogen-stimulated human γδ-T cells permitting the large-scale expansion of these cells. Here we report the innate anti-tumor activity of expanded human γδ-T cells against human breast cancer cells. Apoptosis-resistant human γδ-T cells which were expanded in vitro from cultured human peripheral blood mononuclear cells displayed lytic activity against breast cancer cell lines MDA-MB-231, MCF-7 and T-47D, but failed to kill normal human skin fibroblasts and normal human liver cells. Monoclonal antibodies (mAb) directed against the γδ-T cell receptor (TCR) or mAb directed against either the Vγ9 or the Vδ2 TCR chains were able to block γδ-T cell-mediated lysis of MDA-MB-231 cells. In addition, mAb against intercellular adhesion molecules-1 (ICAM-1/CD54) or CD18 (β subunit of ICAM-1 counter–receptor) also blocked γδ-T cell-mediated killing of MDA-MB-231 cells. Ex vivo expanded human γδ-T cells are thus able to innately recognize and kill human breast cancer cells in a γδ-TCR-dependent manner; ICAM-1 and CD18 also appear to be involved in the interactions between sensitive breast cancer cells and cytolytic γδ-T cells. As apoptosis-resistant human γδ-T cells can now readily be expanded to large numbers (clinical scale), these findings must be considered in the context of developing adoptive immunotherapy strategies to exploit γδ-T cell innate immune responses for the primary or adjuvant treatment of breast cancer.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
K Azuma S Shichijo H Shomura S Matsueda T Fujii K Itoh (2004) ArticleTitleIdentification of HER2/neu-derived peptides capable of inducing both cellular, humoral immune responses in HLA-A24 positive breast cancer patients Breast Cancer Res Treatment 86 IssueID1 19–29 Occurrence Handle10.1023/B:BREA.0000032920.95410.63
F Di Modugno G Bronzi MJ Scanlan et al. (2004) ArticleTitleHuman Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response Int J Cancer 109 IssueID6 909–918 Occurrence Handle10.1002/ijc.20094 Occurrence Handle15027125
ME Gillogly NL Kallinteris M Xu JV Gulfo RE Humphreys JL Murray (2004) ArticleTitleIi-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancer Cancer Immunol Immunother 53 IssueID6 490–496 Occurrence Handle10.1007/s00262-003-0463-y Occurrence Handle14740174
AD Gritzapis NN Sotiriadou M Papamichail CN. Baxevanis (1027) ArticleTitleGeneration of human tumor-specific CTLs in HLA-A2.1-transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumors Cancer Immunol Immunother 53 IssueID11 1027–1040
B Guckel S Stumm C Rentzsch A Marme G Mannhardt D Wallwiener (2005) ArticleTitleA CD80-transfected human breast cancer cell variant induces HER-2/neu-specific T cells in HLA-A*02-matched situations in vitro as well as in vivo Cancer Immunol Immunother 54 IssueID2 129–140 Occurrence Handle10.1007/s00262-004-0583-z Occurrence Handle15365776
JJ Hernando TW Park WC Kuhn (2003) ArticleTitleDendritic cell-based vaccines in breast and gynaecologic cancer Anticancer Res 23 IssueID5b 4293–4303 Occurrence Handle14666641
A Jaramillo K Narayanan LG Campbell et al. (2004) ArticleTitleRecognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients Breast Cancer Res Tr 88 IssueID1 29–41 Occurrence Handle10.1007/s10549-004-8918-1
S Koido M Ohana C Liu et al. (2004) ArticleTitleDendritic cells fused with human cancer cells: morphology, antigen expression, and T cell stimulation Clin Immunol 113 IssueID3 261–269 Occurrence Handle10.1016/j.clim.2004.08.004 Occurrence Handle15507391
Neidhardt-Berard EM, Berard F, Banchereau J, Palucka AK. Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes. Breast Cancer Res 6(4): 2004.
S Oh M Terabe CD Pendleton et al. (2004) ArticleTitleHuman CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cells Cancer Rese 64 IssueID7 2610–2618 Occurrence Handle10.1158/0008-5472.CAN-03-2183
PA Sotiropoulou SA Perez V Voelter et al. (2003) ArticleTitleNatural CD8+ T-cell responses against MHC class I epitopes of the HER-2/ neu oncoprotein in patients with epithelial tumors Cancer Immunol Immunother 52 IssueID12 771–779 Occurrence Handle10.1007/s00262-003-0420-9 Occurrence Handle13680193
K Narayanan A Jaramillo ND Benshoff et al. (2004) ArticleTitleResponse of established human breast tumors to vaccination with mammaglobin-A cDNA J Natl Cancer Instit 96 IssueID18 1388–1396
RA Graham JM Burchell J. Taylor-Papadimitriou (1996) ArticleTitleThe polymorphic epithelial mucin: potential as an immunogen for a cancer vaccine Cancer Immunol Immunother 42 IssueID2 71–80 Occurrence Handle10.1007/s002620050254 Occurrence Handle8620523
C Musselli G Ragupathi T Gilewski KS Panageas Y Spinat PO Livingston (2002) ArticleTitleReevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1 Int J Cancer 97 IssueID5 660–667 Occurrence Handle10.1002/ijc.10081 Occurrence Handle11807794
V Apostolopoulos V Karanikas JS Haurum IF. McKenzie (1997) ArticleTitleInduction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen J Immunol 159 IssueID11 5211–5218 Occurrence Handle9548459
A Segal-Eiras MV. Croce (1997) ArticleTitleBreast cancer associated mucin: a review Allergol Immunopathol (Madr) 25 176–181
GL Palmisano MP Pistillo P Capanni et al. (2001) ArticleTitleInvestigation of HLA class I downregulation in breast cancer by RT-PCR Human Immunol 62 IssueID2 133–139 Occurrence Handle10.1016/S0198-8859(00)00241-X
K Pantel G Schlimok D Kutter et al. (1991) ArticleTitleFrequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells Cancer Res 51 IssueID17 4712–5 Occurrence Handle1873815
A Zia FW Schildberg I Funke (2001) ArticleTitleMHC class I negative phenotype of disseminated tumor cells in bone marrow is associated with poor survival in R0M0 breast cancer patients Int J Cancer 93 IssueID4 566–70 Occurrence Handle10.1002/ijc.1362
V Groh R Rhinehart H Secrist S Bauer KH Grabstein T Spies (1999) ArticleTitleBroad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB Proc Natl Acad Sci U S A 96 IssueID12 6879–6884 Occurrence Handle10.1073/pnas.96.12.6879 Occurrence Handle10359807
S Bauer V Groh J Wu et al. (1999) ArticleTitleActivation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA [see comments] Science 285 IssueID5428 727–729 Occurrence Handle10.1126/science.285.5428.727 Occurrence Handle10426993
V Groh A Steinle S Bauer T Spies (1998) ArticleTitleRecognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells Science 279 IssueID5357 1737–1740 Occurrence Handle10.1126/science.279.5357.1737 Occurrence Handle9497295
F Triebel T Hercend (1989) ArticleTitleSubpopulations of human peripheral T gamma delta lymphocytes.[see comment] Immunol Today 10 IssueID6 186–188 Occurrence Handle10.1016/0167-5699(89)90321-6 Occurrence Handle2526644
V Kunzmann E Bauer J Feurle F Weissinger HP Tony M Wilhelm (2000) ArticleTitleStimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma [see comment] Blood 96 IssueID2 384–392 Occurrence Handle10887096
M Wilhelm V Kunzmann S Eckstein et al. (2003) ArticleTitleGammadelta T cells for immune therapy of patients with lymphoid malignancies Blood 102 IssueID1 200–206 Occurrence Handle10.1182/blood-2002-12-3665 Occurrence Handle12623838
F Ottones J Liautard A Gross F Rabenoelina JP Liautard J Favero (2000) ArticleTitleActivation of human Vgamma9Vdelta2 T cells by a Brucella suis non-peptidic fraction impairs bacterial intracellular multiplication in monocytic infected cells Immunology 100 IssueID2 252–258 Occurrence Handle10.1046/j.1365-2567.2000.00024.x Occurrence Handle10886403
AC Hayday (2000) ArticleTitle[gamma][delta] cells: a right time and a right place for a conserved third way of protection Ann Rev Immunol 18 975–1026 Occurrence Handle10.1146/annurev.immunol.18.1.975
RD Lopez S Xu B Guo RS Negrin EK Waller (2000) ArticleTitleCD2-mediated IL-12-dependent signals render human gamma-delta T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies Blood 96 IssueID12 3827–3837 Occurrence Handle11090067
S Schondelmaier D Wesch K Pechhold D Kabelitz (1993) ArticleTitleV gamma gene usage in peripheral blood gamma delta T cells Immunol Lett 38 121–126 Occurrence Handle10.1016/0165-2478(93)90176-3 Occurrence Handle8294139
K Itoh AB Tilden CM Balch (1986) ArticleTitleInterleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas Cancer Res 46 IssueID6 3011–3017 Occurrence Handle3486040
RJ Medler TL Whiteside NL Vuyanovic JC Hiserodt RB. Herberman (1988) ArticleTitleHuman adherent lymphokine-activated killer cells: a new approach to generating antitumor effectors for adoptive immunotherapy Cancer Res 48 3461 Occurrence Handle3259468
JJ Mule S Shu SL Schwarz SA Rosenberg (1984) ArticleTitleAdoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant IL-2 Science 225 1487–1489 Occurrence Handle6332379
LM Muul EP Director C Hyatt SA Rosenberg (1986) ArticleTitleLarge scale production of human lymphokine activated killer cells for use in adoptive immunotherapy J Immunol Methods 88 265–275 Occurrence Handle10.1016/0022-1759(86)90015-3 Occurrence Handle3485692
SA Rosenberg (1985) ArticleTitleLymphokine-activated killer cells: a new approach to immunotherapy of cancer J Natl Cancer Inst 75 595 Occurrence Handle3876465
SA Rosenberg MT Lotze JJ Mule (1988) ArticleTitleNew approaches to the immunotherapy of cancer using interleukin-2 Ann Intern Med 108 853 Occurrence Handle3285747
PM Schiltz LD Beutel SK Nayak RO Dillman (1997) ArticleTitleCharacterization of tumor-infiltrating lymphocytes derived from human tumors for use as adoptive immunotherapy of cancer J Immunother 20 IssueID5 377–386 Occurrence Handle9336745
SL Topalian LM Muul D Solomon SA Rosenberg (1987) ArticleTitleExpansion of human tumor infiltrating lymphocytes for use in immunotherapy trials J Immunol Methods 102 IssueID1 127–141 Occurrence Handle3305708
WH West KW Tauer JR Yannelli et al. (1987) ArticleTitleConstant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer New Engl J Med 316 898 Occurrence Handle3493433
EWP Nijhuis EW Kemenade CG Figdor RAW Lier Particlevan (1990) ArticleTitleActivation and expansion of tumor-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodies Cancer Immunol Immunother 32 245–250 Occurrence Handle10.1007/BF01741708 Occurrence Handle2175673
IGH Schmidt-Wolf RS Negrin H Kiem KG Blume IL. Weissman (1991) ArticleTitleUse of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity J Exp Med 174 139–149 Occurrence Handle10.1084/jem.174.1.139 Occurrence Handle1711560
SL Topalian D Solomon SA Rosenberg (1989) ArticleTitleTumor-specific cytolysis by lymphocytes infiltrating human melanomas J Immunol 142 IssueID10 3714–3725 Occurrence Handle2785562
H Takahashi T Nakada I Puisieux (1993) ArticleTitleInhibition of human colon cancer growth by antibody-directed human LAK cells in SCID mice Science 259 1469
JR Yannelli C Hyatt S McConnell et al. (1996) ArticleTitleGrowth of tumor-infiltrating lymphocytes from human solid cancers: summary of a 5-year experience Int J Cancer 65 IssueID4 413–421 Occurrence Handle10.1002/(SICI)1097-0215(19960208)65:4<413::AID-IJC3>3.0.CO;2-# Occurrence Handle8621219
MB Bloom D Perry-Lalley PF Robbins et al. (1997) ArticleTitleIdentification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma J Exp Med 185 IssueID3 453–459 Occurrence Handle10.1084/jem.185.3.453 Occurrence Handle9053445
TA Colella TN Bullock LB Russell et al. (2000) ArticleTitleSelf-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy J Exp Medicine 191 IssueID7 1221–1232 Occurrence Handle10.1084/jem.191.7.1221
ME Dudley MI Nishimura AK Holt SA Rosenberg (1999) ArticleTitleAnti-tumor immunization with a minimal peptide epitope (G9–209–2M) leads to a functionally heterogeneous CTL response J Immunother 22 IssueID4 288–298 Occurrence Handle10404430
PR Dunbar JL Chen D Chao et al. (1999) ArticleTitleCutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma J Immunol 162 IssueID12 6959–6962 Occurrence Handle10358133
K Fleischhauer S Tanzarella V Russo et al. (1997) ArticleTitleFunctional heterogeneity of HLA-A*02 subtypes revealed by presentation of a MAGE-3-encoded peptide to cytotoxic T cell clones J Immunol 159 IssueID5 2513–2521 Occurrence Handle9278345
Y Kawakami PF Robbins X Wang et al. (1998) ArticleTitleIdentification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles J Immunol 161 IssueID12 6985–6992 Occurrence Handle9862734
CJ Kim DR Parkinson F Marincola (1998) ArticleTitleImmunodominance across HLA polymorphism: implications for cancer immunotherapy J Immunother 21 IssueID1 1–16 Occurrence Handle9456431
L Mateo J Gardner Q Chen et al. (1999) ArticleTitleAn HLA-A2 polyepitope vaccine for melanoma immunotherapy J Immunol 163 IssueID7 4058–4063 Occurrence Handle10491010
MD McKee TM Clay SA Rosenberg MI Nishimura (1999) ArticleTitleQuantitation of T-cell receptor frequencies by competitive PCR: generation and evaluation of novel TCR subfamily and clone specific competitors J Immunother 22 IssueID2 93–102 Occurrence Handle10093034
B Guo K Hollmig RD Lopez (2002) ArticleTitleDown-regulation of IL-2 receptor a (CD25) characterizes human γδ-T cells rendered resistant to apoptosis after CD2 engagement in the presence of IL-12 Cancer Immunol Immunother 50 625–637 Occurrence Handle10.1007/s00262-001-0244-4 Occurrence Handle11807626
JH Russell (1995) ArticleTitleActivation-induced death of mature T cells in the regulation of immune responses Curr Opin Immunol 7 IssueID3 382–388 Occurrence Handle10.1016/0952-7915(95)80114-6 Occurrence Handle7546404
D Kabelitz K Pechhold A Bender et al. (1991) ArticleTitleActivation and activation-driven death of human gamma/delta T cells Immunol Rev 120 71–88 Occurrence Handle1677929
M Ferrarini S Heltai E Toninelli MG Sabbadini C Pellicciari AA Manfredi (1995) ArticleTitleDaudi lymphoma killing triggers the programmed death of cytotoxic V gamma 9/V delta 2 T lymphocytes J Immunol 154 IssueID8 3704–3712 Occurrence Handle7706713
K Hollmig B Guo RD Lopez (2001) ArticleTitleIn vitro anti-melanoma activity of apoptosis-resistant human γδ-T cells J Clin Oncol 20 254
K Guo B Hollmig RD Lopez (2001) ArticleTitleIn vitro activity of apoptosis-resistant human γδ-T cells against solid malignances J Clin Oncol 20 267
J Wu V Groh T Spies (2002) ArticleTitleT cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma delta T cells J Immunol 169 IssueID3 1236–1240 Occurrence Handle12133944
A Steinle V Groh T Spies (1998) ArticleTitleDiversification, expression, and gamma delta T cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules Proc Natl Acad Sci USA 95 IssueID21 12510–12515 Occurrence Handle10.1073/pnas.95.21.12510 Occurrence Handle9770516
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guo, B.L., Liu, Z., Aldrich, W.A. et al. Innate Anti-breast Cancer Immunity of Apoptosis-resistant Human γδ-T cells. Breast Cancer Res Treat 93, 169–175 (2005). https://doi.org/10.1007/s10549-005-4792-8
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-4792-8